In vivo data presented herein indicate that whilst Nox5 mRNA levels were slightly but significantly lower in PCa compared to benign specimens, there is no significant difference at the protein level (Figures 1 and 2). This evidence concerns the gene NOX5 and posterior cortical atrophy.